Synergistic drug interactions of an HIV-1 protease inhibitor with AZT in different in vitro models of HIV-1 infection

This publication has 24 references indexed in Scilit:

• Human Immunodeficiency Virus Type 1 (HIV-1) Inhibitory Interactions between Protease Inhibitor Ro 31-8959 and Zidovudine, 2',3'-Dideoxycytidine, or Recombinant Interferon- A against Zidovudine-Sensitive or -Resistant HIV-1 In Vitro
  The Journal of Infectious Diseases, 1992
• Hydroxyethylene isostere inhibitors of human immunodeficiency virus-1 protease: structure-activity analysis using enzyme kinetics, x-ray crystallography, and infected T-cell assays
  Biochemistry, 1992
• Human immunodeficiency virus type 1 protease inhibitors irreversibly block infectivity of purified virions from chronically infected cells
  Antimicrobial Agents and Chemotherapy, 1992
• In vitro inhibition of human immunodeficiency virus (HIV) type 1 replication by C2 symmetry-based HIV protease inhibitors as single agents or in combinations
  Antimicrobial Agents and Chemotherapy, 1992
• Design, Activity, and 2.8 Å Crystal Structure of a C ₂ Symmetric Inhibitor Complexed to HIV-1 Protease
  Science, 1990
• The Human Immunodeficiency Virus: Infectivity and Mechanisms of Pathogenesis
  Science, 1988
• Detection of HIV-1 Neutralizing Antibodies by a Simple, Rapid, Colorimetric Assay
  AIDS Research and Human Retroviruses, 1988
• The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related Complex
  New England Journal of Medicine, 1987
• Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors
  Advances in Enzyme Regulation, 1984
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
  Nature, 1970